Summary and Consideration of Priority Areas for Action

Surgeon General's Workshop on Deep Vein Thrombosis

1 | 2 | 3 | 4 | 5 | 6

SLIDE 1: Title — Summary and Consideration of Priority Areas for Action

Surgeon General's Workshop on Deep Vein Thrombosis
9 May 2006

SLIDE 2: Priority Areas

SLIDE 3: Basic Science Research

Identification of biomarkers that can provide individual-specific risk profiles for
- primary thrombosis
- recurrent thrombosis
- long-term management/post-thrombotic syndrome.
Basic endothelial cell biology and vessel response to stasis and thrombosis.

SLIDE 4: Clinical Research

Pharmacology and pharmacokinetic studies of therapies in selected patient populations (pediatric, obesity).
Prospective studies investigating pharmaco-mechanical strategies to decrease clot burden and impact on chronic post-phlebitic syndrome.
Role of pharmacogenetics and warfarin therapy.

SLIDE 5: Education and Training

Develop and promote training programs for students and young physicians interested in careers in venous medicine (e.g. vascular fellowships; competent, capable clot treaters).
Mandate changes in medical education and training.
Increase public awareness efforts on high-risk groups for DVT and PE.

SLIDE 6: Best practices

Awareness/education about the problem—targeting the public as well as providers.
Utilization of thromboprophylaxis to prevent venous thromboembolism.
Implementation of high-quality anticoagulant therapy management.